AVXL   $9.03  6.61% Market Closed After Close 9.1 0.78%

Anavex Life Sciences Corp
Total Cash 138.76M
totalCashPerShare 1.636
EBITDA
Total Debt 0.00
quickRatio 11.951
currentRatio 12.041
Total Revenue
debtToEquity
Revenue/Share
ROA -0.20433001
ROE -0.30034
grossProfits
freeCashflow -19.06M
operatingCashflow -30.00M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 521.80M
forwardPE -12.365079
floatShares 82.21M
sharesOutstanding 84.80M
sharesShort 17.91M
sharesShortPriorMonth 19.61M
dateShortInterest
sharesPercentSharesOut 0.21%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.32%
Short Ratio help_outline 28.27%
shortPercentOfFloat 0.22%
impliedSharesOutstanding
bookValue 1.531
Price To Book help_outline 5.09
earningsQuarterlyGrowth
netIncomeToCommon -41.53M
trailingEps -0.52%
forwardEps -0.63%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.16 3Q 2024
institutionsCount 187
lastUpdated Nov. 7, 2024, 5:18 a.m.